Extended Data Fig. 4: Diastolic blood pressure over time. | Nature Medicine

Extended Data Fig. 4: Diastolic blood pressure over time.

From: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial

Extended Data Fig. 4

Change from baseline in diastolic blood pressure. The effect of semaglutide compared to placebo on estimated diastolic blood pressure was calculated using a MMRM model with two-sided P-values and with fixed effects for treatment, visit, baseline log-transformed UACR, the interaction between treatment and visit, and the interaction between baseline and diastolic blood pressure. Numbers in the lower panel represent the numbers contributing to the mean.

Back to article page